Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer

  • Lisy K
  • 2


    Mendeley users who have this article in their library.
  • 1


    Citations of this article.


Objective: To assess whether histamine type 2 receptor antagonists (H2RAs) improve overall survival when used as pre-, peri-, or postoperative therapy in patients with colorectal cancer who had surgical resection with curative intent.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Karolina Lisy

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free